Qingdao NovelBeam Technology Co.,Ltd. (SHA:688677)
49.47
+0.59 (1.21%)
At close: Jan 23, 2026
SHA:688677 Revenue
Qingdao NovelBeam Technology had revenue of 182.03M CNY in the quarter ending September 30, 2025, with 85.26% growth. This brings the company's revenue in the last twelve months to 571.80M, up 38.44% year-over-year. In the year 2024, Qingdao NovelBeam Technology had annual revenue of 442.83M, down -5.90%.
Revenue (ttm)
571.80M
Revenue Growth
+38.44%
P/S Ratio
10.25
Revenue / Employee
679.90K
Employees
967
Market Cap
5.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 442.83M | -27.77M | -5.90% |
| Dec 31, 2023 | 470.60M | -6.22M | -1.31% |
| Dec 31, 2022 | 476.82M | 167.15M | 53.97% |
| Dec 31, 2021 | 309.67M | 34.48M | 12.53% |
| Dec 31, 2020 | 275.20M | 22.33M | 8.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Blue Sail Medical | 5.78B |
| Allmed Medical Products Co.,Ltd | 3.47B |
| Zhonghong Pulin Medical Products | 2.48B |
| Jiangxi Sanxin Medtec | 1.59B |
| BMC Medical | 1.05B |
| Aidite (Qinhuangdao) Technology | 993.58M |
| Hangzhou Alltest Biotech | 881.63M |
| SWS Hemodialysis Care | 733.59M |